Samantha Lilly, in Ronceverte, WV - Social Worker

Samantha Lilly, is a Social Worker - Clinical based in Ronceverte, West Virginia. Samantha Lilly is licensed to practice in West Virginia (license number BP00946370) and her current practice location is 228 Shamrock Ln, Ronceverte, West Virginia. She can be reached at her office (for appointments etc.) via phone at (304) 497-3900.

NPI number for Samantha Lilly is 1962101527 and her current mailing address is 278 Bumpy Rd, Nimitz, West Virginia. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1962101527.

Contact Information

	Samantha Lilly,
	228 Shamrock Ln, Ronceverte, WV 24970-8380
	(304) 497-3900
	Not Available

Healthcare Provider's Profile

Full Name	Samantha Lilly
Gender	Female
Speciality	Social Worker - Clinical
Location	228 Shamrock Ln, Ronceverte, West Virginia
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1962101527
Provider Enumeration Date: 03/02/2023
Last Update Date: 03/02/2023

Medical Identifiers

Medical identifiers for Samantha Lilly such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1962101527	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
1041C0700X	Social Worker - Clinical	BP00946370 (West Virginia)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Samantha Lilly is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Samantha Lilly, 278 Bumpy Rd, Nimitz, WV 25978 Ph: (304) 777-9049	Samantha Lilly, 228 Shamrock Ln, Ronceverte, WV 24970-8380 Ph: (304) 497-3900

News Archive

Jennerex initiates JX-594 plus irinotecan Phase 1/2 trial in metastatic colorectal cancer

Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, today announced that the first patient has been treated in a Phase 1/2 clinical trial of JX-594 in patients with metastatic colorectal cancer who have become refractory to chemotherapy and are either refractory to or ineligible for cetuximab.

Relationship between binge drinking and depressive symptoms declined 16% among adolescents

Binge drinking among U.S. adolescents precipitously declined from 1991 to 2018, according to a new study at Columbia University Mailman School of Public Health. Depressive symptoms among U.S. adolescents have sharply increased since 2012.

USAID switching to cheaper condoms produced overseas

USAID - which has distributed an estimated 10 billion U.S.-manufactured condoms worldwide - is switching to less-expensive condoms made overseas, the Kansas City Star reports.

NAACP endorses optometric vision therapy at its 100th Anniversary Convention

A routine visit to the eye doctor resulted in a national resolution that was passed by the NAACP at its 100th Anniversary Convention held in New York City, endorsing optometric vision therapy as a way to help some prisoners become productive members of society.

Germ-killing robots use UV radiation to safeguard patients from health care-associated infections

Germ-killing robots are being enlisted to further safeguard Vanderbilt University Medical Center patients from health care-associated infections.

Samantha Lilly, - Clinical Social Worker in Ronceverte, WV